• Report Adverse Event or Product Quality Complaint
  • US Site
  • Global Site
AstraZeneca Medical Information
  • Therapy Areas
    • All Therapeutic Areas
    • Cardiovascular
    • Immunology
    • Infection
    • Metabolic
    • Oncology
    • Renal
    • Respiratory
    • Rare Disease (Alexion)
  • Medications
  • Resources
    • Congress Library
    • Disease Education
    • Pipeline
    • Clinical Trials
    • Open innovation
    • Access 360
    • Affordability Programs
    • Sample Closet
    • Medical Education Grant
    • Rare Disease (Alexion)
  • Connect
    • Connect with Us
    • Find an MSL
    • Request an MSL
    • Submit an MIR
    • Give Feedback
User
  • Login to My AZmedical
  • Register for My AZmedical

Search Medical Information

Heart Failure Association - Heart Failure (ESC-HF HFA) 2024

May 11 - 14, 2024

  1. WAINUA (eplontersen)
  2. FARXIGA (dapagliflozin)

pdf

Cardiac Manifestations as Precursors to ATTR Amyloidosis Diagnosis: Results From the Multi-Country OverTTuRe Study

pdf

In-Hospital Course of Patients With Heart Failure With Improved Ejection Fraction in the DELIVER Trial

pdf

Effects of Dapagliflozin on New-Onset Diabetes in Patients With Heart Failure: A Pooled, Participant-Level Analysis of the DAPA-HF and DELIVER Trials

pdf

Influence of Achieved LVEF on Efficacy of Dapagliflozin in Patients With Heart Failure With Improved Ejection Fraction: The DELIVER Trial

pdf

Health-Related Quality of Life in Women Versus Men With Heart Failure Across the Spectrum of LVEF

pdf

Conventional Medical Therapies in Patients With Heart Failure Across Different Risk for Transthyretin Amyloid Cardiomyopathy in the DELIVER, PARAGON-HF and TOPCAT Americas Trials

pdf

Suspected de Novo Heart Failure in Outpatient Care: High Mortality and Morbidity Rates (REVOLUTION HF)

pdf

Suspected de Novo Heart Failure in Outpatient Care: High Overall Healthcare Costs (REVOLUTION HF)

pdf

Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From Four Large-Scale Placebo-Controlled Outcome Trials

Need Help?

Contact Us

Find an MSL

Chat with a Medical Affairs Associate

Send MIR

Submit a Medical Information Request

Disclaimer

Some content may have changed since publication. Some links may require registration/login to access the content. Any attached publications and/or any tables or figures derived from the publications are copyright-protected works. AstraZeneca has obtained permission from the copyright owner to use this work on this site. You may not reproduce, prepare derivative works from, display or distribute this work unless you obtain the permission of the copyright owner, or as otherwise might be permitted by law.

Request a field medical follow-up

Welcome to AstraZeneca
Medical Information

The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries.

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about AstraZeneca drugs, submit a question, ask for field medical follow-up, and explore links to professional and patient support resources.

Are you a healthcare professional practicing in the United States?

I am an AstraZeneca authorized person   What is an AstraZeneca authorized person?This website is only intended for healthcare professionals practicing in the United States and authorized AstraZeneca personnel. AstraZeneca US Headquarters personnel and US Field Medical personnel are authorized to browse and search the database for their own background knowledge and insight. US Field Sales personnel should not access or browse this site. None of the content of this site should be directly linked or distributed without approval.
I am a payer or formulary decision-maker
I am neither (take me to AstraZeneca.com)
AstraZeneca Logo
Pharma Logo

This site is intended for healthcare professionals practicing in the US.

©2022 AstraZeneca. All rights reserved.

US-69609

Last Updated 11/22

Contact Us

About Us

AstraZeneca-US.com

Grant Opportunities

Survey Feedback

Your Privacy Choices

Privacy Notice

Legal Notice

Cookie Notice

US Site

Global Site

Report Adverse Event or Product Quality Complaint

Pharma Logo

Privacy NoticeLegal NoticeCookie Notice